Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)

Author:

Akechi Tatsuo12ORCID,Yamaguchi Takuhiro3,Uchida Megumi12,Imai Fuminobu12ORCID,Momino Kanae4ORCID,Katsuki Fujika5,Sakurai Naomi6,Miyaji Tempei7,Mashiko Tomoe89,Horikoshi Masaru10,Furukawa Toshi A.11,Yoshimura Akiyo12ORCID,Ohno Shinji13ORCID,Uehiro Natsue13,Higaki Kenji14,Hasegawa Yoshie15,Akahane Kazuhisa16,Uchitomi Yosuke89,Iwata Hiroji12ORCID

Affiliation:

1. Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

2. Division of Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan

3. Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan

4. Department of Nursing Administration and Management, Nagoya City University Graduate School of Nursing, Nagoya, Japan

5. Department of Psychiatric and Mental Health Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan

6. Cancer Solutions Co, Ltd, Tokyo, Japan

7. Department of Clinical Trial Data Management, Tokyo University Graduate School of Medicine, Tokyo, Japan

8. Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo, Japan

9. Institute for Cancer Control, National Cancer Center, Tokyo, Japan

10. National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan

11. Kyoto University Graduate School of Medicine/School of Public Health, Department of Health Promotion of Human Behavior, Kyoto, Japan

12. Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

13. Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan

14. Higaki Breast Clinic, Hiroshima, Japan

15. Department of Breast Surgery, Hachinohe City Hospital, Hachinohe, Aomori, Japan

16. Akahane Breast Clinic, Nagoya, Japan

Abstract

PURPOSE Fear of cancer recurrence (FCR) is a common distressing condition. We investigated the efficacy of smartphone problem-solving therapy and behavioral activation applications in breast cancer survivors. METHODS This was a decentralized randomized trial. Participants were disease-free breast cancer survivors age 20-49 years who were randomly assigned to the smartphone-based intervention or waitlist control. Both groups received treatment as usual. The control group could access the smartphone apps during weeks 8-24. The intervention comprised smartphone problem-solving therapy and behavioral activation apps. The primary end point was the Concerns About Recurrence Scale at week 8. Secondary outcomes included the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF), the Hospital Anxiety and Depression Scale (HADS), the Short-form Supportive Care Needs Survey (SCNS-SF34), and the Posttraumatic Growth Inventory at weeks 8 and 24 (trial registration: UMIN-CTR: UMIN000031140). RESULTS The intervention group included 223 participants, and the control group included 224 participants. Primary outcome data were obtained for 444 participants, and 213 participants in the intervention arm completed the week 24 assessment. The intervention group had statistically greater improvements than controls at week 8 on the Concerns About Recurrence Scale (difference –1.39; 95% CI, –1.93 to –0.85; P < .001), FCRI-SF (difference –1.65; 95% CI, –2.41 to –0.89; P < .001), HADS depression (difference –0.49; 95% CI, –0.98 to 0; P < .05), and SCNS-SF34 psychological domain (difference –1.49; 95% CI, –2.67 to –0.32; P < .05). These scores at week 24 were not statistically significant compared with week 8 although the HADS depression score at week 24 was significantly reduced ( P = .03). CONCLUSION Novel smartphone psychotherapy offers a promising way to reduce FCR given the large number of survivors and a limited number of therapists to competently conduct psychotherapy.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3